Alnylam Pharmaceuticals
ALNY
#649
Rank
โ‚น3.677 T
Marketcap
โ‚น27,546
Share price
-0.61%
Change (1 day)
-1.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company